| Vol. 9.12 – 8 April, 2024 |
| |
|
|
|
Researchers found that nuclear factor kappa-B (NFκB) signaling in cardiac myocytes drove myocardial injury, contractile dysfunction, and arrhythmias in Dsg2mut/mut mice. NFκB signaling in cardiac myocytes mobilized macrophages expressing C-C motif chemokine receptor-2 (CCR2+ cells) to affected areas. [Journal Of Clinical Investigation] |
| | PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Investigators described the function of mitolnc in cardiomyocytes, a nuclear encoded long non-coding RNA, located in mitochondria and directly interacting with the branched-chain ketoacid dehydrogenase (BCKDH) complex to increase its activity. [Nucleic Acids Research] |
|
|
|
| | Researchers found that myofibers form via two distinct phases of fusion and the residual basement membrane of necrotic myofibers was critical for promoting fusion and orienting regenerated myofibers. [Developmental Cell] |
|
|
|
| Scientists showed that the autophagy regulator TP53INP2/TRP53INP2 was decreased during aging in mouse and human skeletal muscle. [Autophagy] |
|
|
|
| To evaluate the impact of capillary versus sarcolemmal proximity, researchers compared the structure and function of skeletal muscle mitochondria located either lateral to embedded capillaries (PVM), adjacent to the sarcolemma but not in PVM pools or interspersed between sarcomeres. [The Journal of Physiology] |
|
|
|
| | Western blotting, PI staining, and LDH release were used to explore the role of circLrch3 in pulmonary arterial smooth muscle cells pyroptosis. [International Journal of Biological Macromolecules] |
|
|
|
| Investigators explored unknown aspects of Krüppel-like factor 15 (KLF15) function. They found that KLF15 expression was reduced in human thoracic aortic dissection (TAD) samples and β-aminopropionitrile monofumarate (BAPN)-induced TAD mouse model. [Journal Of Biological Chemistry] |
|
|
|
|
| The authors discuss myosin heavy chains post-translational modifications (PTMs) that have been biochemically and/or functionally studied in mammals’ and rodents’ striated muscles. [Cytoskeleton] |
|
|
|
|
| Solid Biosciences, Inc. announced that the US FDA has granted Rare Pediatric Disease Designation for SGT-003, the company’s next-generation Duchenne muscular dystrophy gene therapy candidate. [Solid Biosciences, Inc.] |
|
|
|
|
| April 27 – 30, 2024 Barcelona, Spain |
|
|
|
|
|
| University of Technology Sydney – Sydney, New South Wales, Australia |
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| Sapienza University – Rome, Italy |
|
|
|
| Brown University – Providence, Rhode Island, United States |
|
|
|
| French National Institute for Health Research (INSERM) – Nantes, France |
|
|
|
|